Oxford Nanopore Technologies: Unlocking hidden genomic regions for rare disease research

Join us on Corporate Workshop Day to discover how Oxford Nanopore's long-read sequencing is revolutionizing whole genome analysis and rare disease research. First, Scott Hickey from Oxford Nanopore Technologies will demonstrate the performance and utility of any read length nanopore sequencing in identifying challenging medically relevant genes including D4Z4/ DUX4 in FSHD samples. Next, Brian Haynes of Bio-Techne will describe how Asuragen's Carrier Plus assay leverages nanopore sequencing to provide a single, flexible workflow for richer insights in high prevalence carrier screening. Join this Corporate Workshop session to explore innovations reshaping precision medicine and rare disease research.